{"id":211742,"date":"2026-08-19T11:45:52","date_gmt":"2026-08-19T06:15:52","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=211742"},"modified":"2026-08-19T11:45:52","modified_gmt":"2026-08-19T06:15:52","slug":"why-lenskart-solutions-ltd-share-price-52-week-high-2026-08-19","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-lenskart-solutions-ltd-share-price-52-week-high-2026-08-19\/","title":{"rendered":"LENSKART SOLUTIONS LTD (LENSKART) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/lenskart\/lenskart-solutions-ltd-share-price-today\">LENSKART SOLUTIONS LTD<\/a> Share Price rose to Rs 640.25, up 2.05% today, after touching a fresh 52-week high of Rs 641.05. The company\u2019s market capitalisation stood at Rs 1,05,471.53 crore.<\/p>\n<p style=\"margin-top:0!important;\">LENSKART SOLUTIONS LTD Share Price was at Rs 640.25 on 19 August 2026 at 11:41 AM IST, up Rs 12.85 or 2.05% from the previous close of Rs 627.4, after the stock touched a fresh 52-week high of Rs 641.05. With market capitalisation at Rs 1,05,471.53 crore, the one-year high has put the stock firmly on the radar of traders tracking 52 Week High Stocks and investors scanning the Indian Stock Market for market movers.<\/p>\n<p>The supplied data confirms the price event clearly: the stock opened at Rs 632.95, traded between Rs 622.9 and Rs 641.05 during the session, and generated turnover of Rs 39 crore with current volume of 6,09,099 shares. That combination places LENSKART SOLUTIONS LTD Share Price Today among notable Stock Updates for Share Market Today and reinforces why the counter is appearing in Stocks in News screens.<\/p>\n<p>What is also relevant is valuation context. On the supplied numbers, the company trades at a P\/E ratio of 51.17 and a P\/B ratio of 2.03, while return ratios stand at ROE of -0.78 and ROCE of 8.31. Within the Healthcare sector benchmark of 196 companies, those figures give investors a factual starting point for LENSKART SOLUTIONS LTD Fundamental Analysis. Univest notes that the fresh 52-week peak is established by price data, while the supplied data does not establish a company-specific catalyst behind today\u2019s move. For now, investors will likely monitor whether turnover, valuation context and peer positioning continue to support attention around LENSKART SOLUTIONS LTD Stock News.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"LENSKART_SOLUTIONS_LTD_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>LENSKART SOLUTIONS LTD Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 640.25<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 627.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 12.85 (+2.05%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 632.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 641.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 622.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6,09,099<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 39 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,05,471.53 crore<\/td>\n<\/tr>\n<\/table>\n<p>LENSKART SOLUTIONS LTD (LENSKART) traded at Rs 640.25. versus the previous close of Rs 627.4, a rise of 2.05%. The stock opened at Rs 632.95, reached Rs 641.05, touched Rs 622.9. Reported volume was 6,09,099.<\/p>\n<p>LENSKART SOLUTIONS LTD Share Price Today moved higher in a session that combined a positive gap from the previous close with an intraday push to a fresh 52-week high. The stock opened at Rs 632.95 against the previous close of Rs 627.4, climbed to Rs 641.05, slipped to an intraday low of Rs 622.9, and was last seen at Rs 640.25, up Rs 12.85 or 2.05%.<\/p>\n<p>This trading pattern shows that buyers were active early, but the session also saw some price swings because the day\u2019s range stretched from Rs 622.9 to Rs 641.05. Even so, the stock holding close to the day high matters for short-term price action analysis, as it suggests the yearly high was not merely a fleeting print. For traders following LENSKART SOLUTIONS LTD Share Price Live and LENSKART SOLUTIONS LTD News Today, the stock remained close to the strongest level seen in the session.<\/p>\n<p>Turnover stood at Rs 39 crore and traded volume reached 6,09,099 shares. Those figures help explain why LENSKART SOLUTIONS LTD Share News has entered the broader Market News conversation today. A fresh 52-week peak often attracts additional attention because it resets the stock\u2019s one-year reference point, and that alone can make it visible among Breakout Stocks, Momentum Stocks and Top Gainers Today screens. Univest would frame today\u2019s move as a verified price event with clear trading participation, which naturally shifts the discussion from price action to whether the underlying financial profile supports continued investor attention.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"LENSKART_SOLUTIONS_LTD_LENSKART_Fundamental_Analysis\"><\/span><strong>LENSKART SOLUTIONS LTD (LENSKART) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,05,471.53 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.03x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.31%<\/td>\n<\/tr>\n<\/table>\n<p>LENSKART SOLUTIONS LTD was valued at a P\/E ratio of 51.17x, a P\/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">51.17x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.79x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">47.16x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 1,635.98x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.03x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.9x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-0.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.31%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.29%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,05,471.53 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 134.22 crore<\/td>\n<\/tr>\n<\/table>\n<p>LENSKART SOLUTIONS LTD (LENSKART) is classified under sector: Healthcare.<\/p>\n<p>LENSKART SOLUTIONS LTD (LENSKART) has a P\/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>LENSKART SOLUTIONS LTD (LENSKART) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. LENSKART SOLUTIONS LTD (LENSKART) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-swift-laboratories-ltd-share-price-today\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,724.51<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">51.17<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.03<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.78<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.31<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,697.08<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">62.93<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,583.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.99<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.29<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">42.4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,431.62<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">167.79<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.07<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\"><strong>Fredun Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">FREDUN<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,403.56<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">54.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.42<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.15<\/td>\n<\/tr>\n<\/table>\n<p>LENSKART SOLUTIONS LTD (LENSKART) has a P\/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. LENSKART SOLUTIONS LTD (LENSKART) has a market capitalisation of Rs 1,05,471.53 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_LENSKART_SOLUTIONS_LTD\"><\/span><strong>Why Investors Are Watching LENSKART SOLUTIONS LTD<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This stock is attracting attention because the supplied data presents a clear event-led setup for both short-term market watchers and longer-term fundamental readers.<\/p>\n<ul>\n<li><strong>Fresh price event:<\/strong> LENSKART SOLUTIONS LTD Share Price touched a new 52-week high of Rs 641.05 and was trading at Rs 640.25, up 2.05%.<\/li>\n<li><strong>Active session:<\/strong> The stock traded between Rs 622.9 and Rs 641.05 with volume of 6,09,099 shares and turnover of Rs 39 crore.<\/li>\n<li><strong>Large market value:<\/strong> Market capitalisation of Rs 1,05,471.53 crore is far above the supplied Healthcare benchmark median and average.<\/li>\n<li><strong>Valuation focus:<\/strong> P\/E at 51.17 is above the sector median of 20.79 and average of 47.16, while P\/B at 2.03 is closer to the benchmark range.<\/li>\n<li><strong>Profitability contrast:<\/strong> ROE of -0.78 and ROCE of 8.31 are below sector medians of 11.09 and 13.29, respectively.<\/li>\n<li><strong>Peer positioning:<\/strong> The company\u2019s scale is far larger than the supplied peers, but return metrics are weaker than several of them.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_LENSKART_SOLUTIONS_LTD\"><\/span><strong>About LENSKART SOLUTIONS LTD<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>LENSKART SOLUTIONS LTD is identified in the supplied data as a listed company within the Healthcare sector and trades under the symbol LENSKART. In today\u2019s market context, the company is being discussed primarily because of its stock performance rather than because of any separately supplied business update. That makes the current article a price-led and data-led stock analysis built around verified market information.<\/p>\n<p>From the available fields, the most important company context is its sector placement and scale. With a market capitalisation of Rs 1,05,471.53 crore, LENSKART SOLUTIONS LTD stands out as a very large listed name relative to the 196-company Healthcare benchmark supplied for comparison. Investors following LENSKART SOLUTIONS LTD Company News, LENSKART SOLUTIONS LTD NSE coverage and LENSKART SOLUTIONS LTD BSE updates are therefore likely to view the stock through a mix of market-cap leadership, valuation and sector-relative profitability.<\/p>\n<p>Univest will typically place such a company in the category of actively tracked market names because fresh 52-week peaks tend to draw attention from both momentum-oriented traders and investors comparing fundamentals across the Healthcare space.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_LENSKART_SOLUTIONS_LTD_Share_Price_on_Univest\"><\/span><strong>Track LENSKART SOLUTIONS LTD Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/lenskart\/lenskart-solutions-ltd-share-price-today\">LENSKART SOLUTIONS LTD (LENSKART) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Readers tracking LENSKART SOLUTIONS LTD Share Price can use Univest to monitor live share price moves, 52-week levels, market capitalisation, valuation ratios, sector comparisons and peer positioning in one place. For stocks making a fresh yearly high, that combination helps investors connect the day\u2019s price action with broader stock analysis.<\/p>\n<p>Univest also helps users follow LENSKART SOLUTIONS LTD Share Price Today alongside turnover, volume trends, P\/E, P\/B, ROE, ROCE and benchmark comparisons within Healthcare. For investors who regularly scan Stock Market Today, NSE News, BSE News and Market Trends, that integrated view is often useful when a stock enters the spotlight because of a new one-year high.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_LENSKART_SOLUTIONS_LTD_Share_Price_today\"><\/span><strong>What is LENSKART SOLUTIONS LTD Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> LENSKART SOLUTIONS LTD Share Price was Rs 640.25 at 11:41 AM IST on 19 August 2026. The stock was up Rs 12.85, or 2.05%, from the previous close of Rs 627.4 in the same session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_LENSKART_SOLUTIONS_LTD_hit_a_52-week_high_today\"><\/span><strong>Did LENSKART SOLUTIONS LTD hit a 52-week high today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, LENSKART SOLUTIONS LTD touched a fresh 52-week high of Rs 641.05 during the session. The stock later traded at Rs 640.25, showing that it remained close to the day\u2019s strongest level after the breakout.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_LENSKART_SOLUTIONS_LTD_Share_Price_rising_today\"><\/span><strong>Why is LENSKART SOLUTIONS LTD Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that the stock rose 2.05% and hit a fresh 52-week high, supported by Rs 39 crore turnover and 6,09,099 shares traded. It does not establish a separate company-specific catalyst behind today\u2019s move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_day_range_for_LENSKART_SOLUTIONS_LTD_Share_Price_Today\"><\/span><strong>What was the day range for LENSKART SOLUTIONS LTD Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> LENSKART SOLUTIONS LTD Share Price Today traded between Rs 622.9 and Rs 641.05. The stock opened at Rs 632.95, moved above the previous close of Rs 627.4, and reached a new one-year high during trading.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_LENSKART_SOLUTIONS_LTD\"><\/span><strong>What is the market capitalisation of LENSKART SOLUTIONS LTD?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> LENSKART SOLUTIONS LTD Market Cap stood at Rs 1,05,471.53 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 134.22 crore and average of Rs 465.93 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_LENSKART_SOLUTIONS_LTD_expensive_compared_with_the_Healthcare_sector\"><\/span><strong>Is LENSKART SOLUTIONS LTD expensive compared with the Healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On supplied valuation data, the stock trades at a P\/E of 51.17 versus the Healthcare sector median of 20.79 and average of 47.16. Its P\/B of 2.03 is slightly above the median 1.9 and below the average 2.57.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_do_LENSKART_SOLUTIONS_LTD_ROE_and_ROCE_compare_with_the_sector\"><\/span><strong>How do LENSKART SOLUTIONS LTD ROE and ROCE compare with the sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> LENSKART SOLUTIONS LTD has an ROE of -0.78 and ROCE of 8.31. Both figures are below the Healthcare sector median levels of 11.09 and 13.29, and also below the averages of 15.58 and 17.78.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_LENSKART_SOLUTIONS_LTD_compare_with_selected_peers\"><\/span><strong>How does LENSKART SOLUTIONS LTD compare with selected peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E of 51.17 matches Ind-Swift Laboratories, is below Beta Drugs at 62.93 and Sai Parenteral&#39;s at 167.79, and above Dr Agarwals at 33.9. Its market capitalisation is much larger than all supplied peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_does_LENSKART_SOLUTIONS_LTD_belong_to\"><\/span><strong>Which sector does LENSKART SOLUTIONS LTD belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> LENSKART SOLUTIONS LTD belongs to the Healthcare sector in the supplied dataset. The benchmark comparison used in this article covers 196 same-sector companies, which provides context for valuation, market-cap and profitability analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_after_this_fresh_52-week_high\"><\/span><strong>What should investors monitor after this fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may track whether LENSKART SOLUTIONS LTD holds near the fresh 52-week high of Rs 641.05, how volume and turnover evolve, and how the stock\u2019s P\/E, P\/B, ROE and ROCE compare with sector benchmarks and peers.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>LENSKART SOLUTIONS LTD Share Price hits a new 52-week high at Rs 640.25. marking a 2.05% rise today. Market cap stands at Rs 1,05,471.53 crore.<\/p>\n","protected":false},"author":29,"featured_media":211739,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-211742","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["211739"],"rank_math_title":["LENSKART SOLUTIONS LTD Share Price at Fresh 52-Week High"],"rank_math_description":["LENSKART SOLUTIONS LTD Share Price hit a fresh 52-week high at Rs 641.05. Read price action, valuation, peer comparison and sector analysis."],"rank_math_focus_keyword":["LENSKART SOLUTIONS LTD Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/LENSKART_SOLUTIONS_LTD_LENSKART_Share_Price_Hits_Fresh_52_Week_High_bullish-7.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/211742","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=211742"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/211742\/revisions"}],"predecessor-version":[{"id":211743,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/211742\/revisions\/211743"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/211739"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=211742"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=211742"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=211742"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}